GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (OTCPK:OKAIF) » Definitions » EV-to-FCF

OKAIF (EvokAI Creative Labs) EV-to-FCF : -1.76 (As of Jan. 18, 2025)


View and export this data going back to 2022. Start your Free Trial

What is EvokAI Creative Labs EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, EvokAI Creative Labs's Enterprise Value is $2.16 Mil. EvokAI Creative Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.23 Mil. Therefore, EvokAI Creative Labs's EV-to-FCF for today is -1.76.

The historical rank and industry rank for EvokAI Creative Labs's EV-to-FCF or its related term are showing as below:

OKAIF' s EV-to-FCF Range Over the Past 10 Years
Min: -396.16   Med: 0   Max: 0
Current: -1.64

OKAIF's EV-to-FCF is ranked worse than
100% of 408 companies
in the Healthcare Providers & Services industry
Industry Median: 18.68 vs OKAIF: -1.64

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-01-18), EvokAI Creative Labs's stock price is $0.0303. EvokAI Creative Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.184. Therefore, EvokAI Creative Labs's PE Ratio (TTM) for today is At Loss.


EvokAI Creative Labs EV-to-FCF Historical Data

The historical data trend for EvokAI Creative Labs's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EvokAI Creative Labs EV-to-FCF Chart

EvokAI Creative Labs Annual Data
Trend Dec21 Dec22 Dec23
EV-to-FCF
- - -1.68

EvokAI Creative Labs Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -36.99 -1.68 -2.74 -3.31 -1.83

Competitive Comparison of EvokAI Creative Labs's EV-to-FCF

For the Health Information Services subindustry, EvokAI Creative Labs's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EvokAI Creative Labs's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EvokAI Creative Labs's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where EvokAI Creative Labs's EV-to-FCF falls into.



EvokAI Creative Labs EV-to-FCF Calculation

EvokAI Creative Labs's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2.159/-1.227
=-1.76

EvokAI Creative Labs's current Enterprise Value is $2.16 Mil.
EvokAI Creative Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EvokAI Creative Labs  (OTCPK:OKAIF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

EvokAI Creative Labs's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0303/-0.184
=At Loss

EvokAI Creative Labs's share price for today is $0.0303.
EvokAI Creative Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.184.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


EvokAI Creative Labs EV-to-FCF Related Terms

Thank you for viewing the detailed overview of EvokAI Creative Labs's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


EvokAI Creative Labs Business Description

Traded in Other Exchanges
Address
609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.